During the past decade, Taipei Tzu Chi General Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Taipei Tzu Chi General Hospital" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "National Taiwan University Hospital" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Taipei Tzu Chi General Hospital" #1 collaborator was "Chiayi Christian Hospital" with 1 trials as a collaborator, "Dalin Tzu Chi General Hospital" with 1 trials as a collaborator, "E-DA Hospital" with 1 trials as a collaborator, "Everest Medicines" with 1 trials as a collaborator and "National Taiwan University Hospital, Yun-Lin Branch" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Taipei Tzu Chi General Hospital" are "Inguinal Hernia" (2 trials), "Breast Neoplasm" (1 trials), "Breast Neoplasms" (1 trials), "Chronic Hepatitis b" (1 trials) and "HER2+ Metastatic Breast Cancer (MBC)" (1 trials). Many other conditions were trialed in "Taipei Tzu Chi General Hospital" in a lesser frequency.

Most popular intervention types in "Taipei Tzu Chi General Hospital" are "Drug" (6 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (1 trials), "Anastrozole" (1 trials), "Docetaxel" (1 trials), "Exemestane" (1 trials) and "Fulvestrant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Taipei Tzu Chi General Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Taipei Tzu Chi General Hospital". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Taipei Tzu Chi General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Taipei Tzu Chi General Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".